Home › Pulmonary Arterial Hypertension › Florida
Pulmonary Arterial Hypertension clinical trials in Florida
6 studies for Pulmonary Arterial Hypertension are looking for participants at sites in Florida.
Cities in Florida
A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults
- Investigational Site-102, Tampa
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT07143448A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Mayo Clinic of Florida, Jacksonville
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 10, 2026 · NCT07175038Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- University of Florida Health, Gainesville
- Mayo Clinic Jacksonville, Jacksonville
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jul 29, 2026 · NCT06274801A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- Central Florida Pulmonary Group, Orlando
- University of South Florida, Tampa
RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Jul 21, 2026 · NCT06649110Pulmonary Hypertension Association Registry
- Mayo Clinic Florida, Jacksonville
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT04071327Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
- Johns Hopkins All Children's Heart Institute, St. Petersburg
RecruitingObservational study
1 Day – 21 Years · All sexes · Updated Mar 13, 2025 · NCT02249923From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.